Apellis Pharmaceuticals I...

18.20
0.04 (0.22%)
At close: Apr 17, 2025, 3:59 PM
18.15
-0.27%
Pre-market: Apr 21, 2025, 06:07 AM EDT

Apellis Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016
709.95M 396.59M 75.42M 66.56M 250.65M n/a n/a n/a n/a
117.72M 58.51M 5.64M 5.2M 25.05M 288.02M 127.92M 50.77M n/a
592.23M 338.08M 69.79M 61.36M 225.6M -288.02M -127.92M -50.77M n/a
-236.39M -517.12M -594.61M -536.28M -213.73M -288.02M -127.92M -50.77M -27.28M
12.77M 20.93M 8.91M 418K 4.16M 5.11M 2.96M n/a n/a
-196.72M -526.5M -651.5M -746M -343.03M -304.71M -127.5M -51.01M -27.12M
-197.88M -528.63M -652.17M -746.35M -344.87M -309.82M -127.5M -51.01M -27.12M
501.05M 500.81M 277.16M 176.77M 139.4M 67.05M 22.64M 10.46M 4.3M
327.57M 354.39M 387.24M 420.87M 299.92M 220.97M 105.29M 40.3M 22.98M
n/a n/a -288K 1.36M -501K -175.31K -110.76K 11.54K 157.71K
828.62M 855.2M 664.4M 597.64M 439.32M 288.02M 127.92M 50.77M 27.28M
40.39M 29.58M 32.63M 13.24M 29.94M 5.28M 2.51M 96.92K n/a
n/a n/a n/a n/a n/a n/a n/a n/a n/a
946.35M 913.71M 670.03M 602.84M 464.37M 288.02M 127.92M 50.77M 27.28M
1.16M 2.13M 669K 352K 1.84M 5.11M -533.32K 250.61K -27.28M
123.9M 118.68M 106.11M 84.42M 75.16M 62.23M 54.4M 13.87M 18.09M
123.9M 118.68M 106.11M 84.42M 75.16M 62.23M 54.4M 13.87M 18.09M
-1.6 -4.45 -6.15 -8.84 -4.59 -4.98 -2.34 -3.68 -1.5
-1.6 -4.45 -6.15 -8.84 -4.59 -4.98 -2.34 -3.68 -1.5
-236.39M -495.21M -617.39M -731.27M -312.23M -298.83M n/a -50.9M 157.71K
-237.11M -496.92M -618.88M -732.76M -313.09M -288.01M -124.99M -50.91M -27.12M
1.8M 1.7M 1.49M 1.49M 859K 595.45K 127.92M 11.94K 27.28M